Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1850 9 |
Ultima descărcare din IBN: 2024-04-08 12:45 |
SM ISO690:2012 BOLDESCU, Veaceslav, KRUDU, V., SUCMAN, Natalia, POGREBNOI, Serghei, ZVEAGHINTSEVA, Marina, STYNGACH, Evgenia, POGREBNOI, Vsevolod, MAKAEV, Fliur. Molecular concepts of macrophage targeting. In: Chemistry Journal of Moldova, 2013, nr. 2(8), pp. 21-31. ISSN 1857-1727. DOI: https://doi.org/10.19261/cjm.2013.08(2).02 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Chemistry Journal of Moldova | ||||||
Numărul 2(8) / 2013 / ISSN 1857-1727 /ISSNe 2345-1688 | ||||||
|
||||||
DOI:https://doi.org/10.19261/cjm.2013.08(2).02 | ||||||
Pag. 21-31 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Macrophages play an important role in the pathological development of such disorders as cancer, inflammatory and certain infectious diseases, such as tuberculosis, HIV, dengue virus, and leishmaniasis. Therefore, macrophage targeting represents an important challenge in design of new medicines. This review gives a general presentation of small molecule-recognition concepts with application in drug design for macrophage targeting. It describes different mechanisms and systems for macrophage-targeted delivery, including ligands or small molecule motifs recognizable by macrophage specific proteins, like receptors (e. g. sialoadhesin, folate, galactose, mannose,β-glucan, and scavenger, tuftsin receptors) or enzymes (carboxylesterase-1), pathways for their obtaining and routes of their application. |
||||||
Cuvinte-cheie macrophage receptor targeting, macrophage enzyme targeting, inflammatory disorders, tuberculosis, cancer. |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-29261</cfResPublId> <cfResPublDate>2013-07-01</cfResPublDate> <cfVol>8</cfVol> <cfIssue>2</cfIssue> <cfStartPage>21</cfStartPage> <cfISSN>1857-1727</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/29261</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Molecular concepts of macrophage targeting</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>macrophage receptor targeting; macrophage enzyme targeting; inflammatory disorders; tuberculosis; cancer.</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'>Macrophages play an important role in the pathological development of such disorders as cancer, inflammatory and certain infectious diseases, such as tuberculosis, HIV, dengue virus, and leishmaniasis. Therefore, macrophage targeting represents an important challenge in design of new medicines. This review gives a general presentation of small molecule-recognition concepts with application in drug design for macrophage targeting. It describes different mechanisms and systems for macrophage-targeted delivery, including ligands or small molecule motifs recognizable by macrophage specific proteins, like receptors (e. g. sialoadhesin, folate, galactose, mannose,β-glucan, and scavenger, tuftsin receptors) or enzymes (carboxylesterase-1), pathways for their obtaining and routes of their application.</cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-14228</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11018</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-12497</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-15826</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-12494</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-12184</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-36448</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-4389</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-29261</cfFedIdId> <cfFedId>10.19261/cjm.2013.08(2).02</cfFedId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-14228</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-14228-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Boldescu</cfFamilyNames> <cfFirstNames>Veaceslav</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11018</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11018-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Krudu</cfFamilyNames> <cfFirstNames>V.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-12497</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12497-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Сукман</cfFamilyNames> <cfFirstNames>Наталья</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-15826</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-15826-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Pogrebnoi</cfFamilyNames> <cfFirstNames>Serghei</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-12494</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12494-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Zveaghintseva</cfFamilyNames> <cfFirstNames>Marina</cfFirstNames> <cfFamilyNames>Звягинцева</cfFamilyNames> <cfFirstNames>Марина</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-12184</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12184-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Styngach</cfFamilyNames> <cfFirstNames>Evgenia</cfFirstNames> <cfFamilyNames>Стынгач</cfFamilyNames> <cfFirstNames>Евгения</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-36448</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-36448-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Погребной</cfFamilyNames> <cfFirstNames>Всеволод</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-4389</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-4389-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-07-01T24:00:00</cfStartDate> <cfFamilyNames>Makaev</cfFamilyNames> <cfFirstNames>Fliur</cfFirstNames> <cfFamilyNames>Макаев</cfFamilyNames> <cfFirstNames>Флюр</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>